 | TB/HIV: a Clinical Manual (WHO - OMS, 1996, 135 p.) |
 |  | Chapter 12 - Prevention of TB in HIV-infected individuals |
| | 12.3 The role of BCG in preventing TB in HIV-infected individuals |
|
|
12.3.4 WHO recommended policy on BCG and HIV
WHO recommended policy depends on the TB prevalence in a country, as shown on the next page. In a high TB prevalence country, the possible benefits of BCG immunisation outweigh the possible disadvantages.
|
COUNTRY TB PREVALENCE |
WHO RECOMMENDED POLICY |
|
high |
BCG for all children (according to standard programme) except children with symptoms of HIV disease/AIDS |
|
low |
Do not give BCG immunisation to HIV-infected children |
|
|